Insulin Pumps - Medical Devices Pipeline Assessment, 2018

Insulin Pumps - Medical Devices Pipeline Assessment, 2018

Summary

GlobalDatas Medical Devices sector report, Insulin Pumps - Medical Devices Pipeline Assessment, 2018" provides an overview of Insulin Pumps currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Insulin Pumps pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalDatas team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Insulin Pumps under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Insulin Pumps and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry.

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Insulin Pumps under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the products current stage of development, territory and estimated launch date


1.1 List of Tables 6
1.2 List of Figures 7
2 Introduction 8
2.1 Insulin Pumps Overview 8
3 Products under Development 9
3.1 Insulin Pumps - Pipeline Products by Stage of Development 9
3.2 Insulin Pumps - Pipeline Products by Segment 10
3.3 Insulin Pumps - Pipeline Products by Territory 11
3.4 Insulin Pumps - Pipeline Products by Regulatory Path 12
3.5 Insulin Pumps - Pipeline Products by Estimated Approval Date 13
3.6 Insulin Pumps - Ongoing Clinical Trials 14
4 Insulin Pumps - Pipeline Products under Development by Companies 15
4.1 Insulin Pumps Companies - Pipeline Products by Stage of Development 15
4.2 Insulin Pumps - Pipeline Products by Stage of Development 16
5 Insulin Pumps Companies and Product Overview 17
5.1 Amrita Vishwa Vidyapeetham Company Overview 17
5.1.1 Amrita Vishwa Vidyapeetham Pipeline Products & Ongoing Clinical Trials Overview 17
5.2 Andain, Inc Company Overview 18
5.2.1 Andain, Inc Pipeline Products & Ongoing Clinical Trials Overview 18
5.3 Cam Med LLC Company Overview 20
5.3.1 Cam Med LLC Pipeline Products & Ongoing Clinical Trials Overview 20
5.4 Cellnovo Ltd Company Overview 21
5.4.1 Cellnovo Ltd Pipeline Products & Ongoing Clinical Trials Overview 21
5.5 Debiotech SA Company Overview 23
5.5.1 Debiotech SA Pipeline Products & Ongoing Clinical Trials Overview 23
5.6 Hospira Inc Company Overview 25
5.6.1 Hospira Inc Pipeline Products & Ongoing Clinical Trials Overview 25
5.7 Insulet Corp Company Overview 26
5.7.1 Insulet Corp Pipeline Products & Ongoing Clinical Trials Overview 26
5.8 LifeScan Inc Company Overview 28
5.8.1 LifeScan Inc Pipeline Products & Ongoing Clinical Trials Overview 28
5.9 MedSolve Technologies, Inc. Company Overview 29
5.9.1 MedSolve Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 29
5.10 MicroPort Scientific Corp Company Overview 30
5.10.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 30
5.11 Phluid Corporation Company Overview 32
5.11.1 Phluid Corporation Pipeline Products & Ongoing Clinical Trials Overview 32
5.12 Roche Diabetes Care Inc Company Overview 33
5.12.1 Roche Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview 33
5.13 Sensile Medical AG Company Overview 36
5.13.1 Sensile Medical AG Pipeline Products & Ongoing Clinical Trials Overview 36
5.14 SFC Fluidics LLC Company Overview 37
5.14.1 SFC Fluidics LLC Pipeline Products & Ongoing Clinical Trials Overview 37
5.15 Spring Health Solutions Ltd. Company Overview 39
5.15.1 Spring Health Solutions Ltd. Pipeline Products & Ongoing Clinical Trials Overview 39
5.16 Tandem Diabetes Care Inc Company Overview 40
5.16.1 Tandem Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview 40
5.17 Univlabs Technologies Pvt Ltd Company Overview 43
5.17.1 Univlabs Technologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 43
5.18 ViCentra BV Company Overview 44
5.18.1 ViCentra BV Pipeline Products & Ongoing Clinical Trials Overview 44
5.19 Ypsomed Holding AG Company Overview 45
5.19.1 Ypsomed Holding AG Pipeline Products & Ongoing Clinical Trials Overview 45
6 Insulin Pumps- Recent Developments 47
6.1 Apr 18, 2018: Abbott Reports First-Quarter 2018 Results 47
6.2 Apr 11, 2018: Zealand and Roche Diabetes Care enter Phase 3 study collaboration for treatment of congenital hyperinsulinism with dasiglucagon 49
6.3 Apr 10, 2018: Tandem Diabetes Care Announces Preliminary First Quarter 2018 Results 50
6.4 Apr 09, 2018: Tandem Diabetes Care and Movi SpA Announce Agreement for Distribution of Insulin Pump Products in Italy 50
6.5 Apr 05, 2018: Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics 51
6.6 Mar 28, 2018: MicroPort Scientific Announces 2017 Annual Results 51
6.7 Mar 27, 2018: Ypsomed Expands to North America 53
6.8 Mar 27, 2018: MicroPort Scientific Announces Year Ended 31 December 2017 Financial Results 54
6.9 Mar 09, 2018: Maura Dickler, M.D. To Become Vice President Of Late Phase Development At Lilly Oncology 54
6.10 Mar 08, 2018: Changes to the Roche Enlarged Corporate Executive Committee 55
6.11 Mar 01, 2018: Tandem Diabetes Care Announces 2017 Financial Results 55
6.12 Feb 22, 2018: Integer Holdings Reports Results for Fourth Quarter and Full Year 2017 57
6.13 Feb 22, 2018: Integer Announces Strategy Focused on Portfolio Management and Operational Excellence; Aligns Senior Management to Execute Strategic Imperatives 58
6.14 Feb 21, 2018: Insulet Reports Fourth Quarter Revenue of $130.5 Million In Fourth Quarter Of 2017 59
6.15 Feb 15, 2018: Reduced Time in Hypoglycemia Demonstrated in Tandem Diabetes Cares Pivotal Trial for the t:slim X2 Insulin Pump with Predictive Low Glucose Suspend Feature; Data to be Presented at ATTD 2018 Conference 61
6.16 Feb 15, 2018: Tandem Diabetes Care and Rubin Medical Announce Agreement for Distribution of Insulin Pump Products in Scandinavia 61
6.17 Feb 15, 2018: ConvaTec Group Annual Results 2017 62
6.18 Feb 15, 2018: ConvaTec Group Reports Annual Financial Results For 2017 63
6.19 Feb 12, 2018: Integer Elects James Hinrichs to its Board of Directors 69
6.20 Feb 08, 2018: MicroPort Signs Strategic Agreement with Neptunus Biotechnology 70
6.21 Feb 05, 2018: JDRF and Cam Med Partner to Develop Flexible Patch Pump for Automated Insulin Delivery Systems 70
6.22 Feb 01, 2018: Roche reports good results in 2017 71
6.23 Jan 31, 2018: Lilly Reports Strong Fourth-Quarter and Full-Year 2017 Revenue Growth, Increases 2018 EPS Guidance 71
6.24 Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronics Greater China Region 78
6.25 Jan 24, 2018: Abbott Reports Fourth-Quarter 2017 Results 78
6.26 Jan 16, 2018: OrthoXel Announce FDA 510k and CE Mark Approval for their Orthopaedic Trauma Product the Apex Tibial Nail System 81
6.27 Jan 09, 2018: MicroPort Selected as "2017 China Innovative Medical Device Company" 82
6.28 Jan 09, 2018: MicroPort Awarded 2017 Shanghai Pilot Enterprise with Outstanding Innovation 82
6.29 Jan 09, 2018: Tandem Diabetes Care Announces Preliminary 2017 Results and Provides 2018 Guidance 83
6.30 Jan 08, 2018: Tandem Diabetes Care Reports Successful Completion of First Pilot Study Using t:slim X2 Insulin Pump with TypeZero Hybrid Closed Loop Technology and Dexcom G6 Integration; Confirms IDCL Multi-site Study Timeline 84
6.31 Jan 08, 2018: MicroPort Lifesciences Displayed La Fenice Insulin Pump at CDS2017 85
6.32 Jan 03, 2018: Tandem Diabetes Care Commences Full Manufacturing Operations at New San Diego Facility 85
6.33 Jan 02, 2018: Integer Names Kirk Thor Chief Human Resources Officer 86
7 Appendix 174
7.1 Methodology 174
7.2 About GlobalData 177
7.3 Contact Us 177
7.4 Disclaimer 177

List Of Tables

1.1 List of Tables
Table 1: Insulin Pumps - Pipeline Products by Stage of Development 9
Table 2: Insulin Pumps - Pipeline Products by Segment 10
Table 3: Insulin Pumps - Pipeline Products by Territory 11
Table 4: Insulin Pumps - Pipeline Products by Regulatory Path 12
Table 5: Insulin Pumps - Pipeline Products by Estimated Approval Date 13
Table 6: Insulin Pumps - Ongoing Clinical Trials 14
Table 7: Insulin Pumps Companies - Pipeline Products by Stage of Development 15
Table 8: Insulin Pumps - Pipeline Products by Stage of Development 16
Table 9: Amrita Vishwa Vidyapeetham Pipeline Products & Ongoing Clinical Trials Overview 17
Table 10: Amrita Insulin Pump - Product Status 17
Table 11: Amrita Insulin Pump - Product Description 17
Table 12: Andain, Inc Pipeline Products & Ongoing Clinical Trials Overview 18
Table 13: Gaia Med Diamond Semi-Disposable Pump - Product Status 18
Table 14: Gaia Med Diamond Semi-Disposable Pump - Product Description 18
Table 15: Gemini Pump - Product Status 18
Table 16: Gemini Pump - Product Description 19
Table 17: Cam Med LLC Pipeline Products & Ongoing Clinical Trials Overview 20
Table 18: Evopump - Product Status 20
Table 19: Evopump - Product Description 20
Table 20: Cellnovo Ltd Pipeline Products & Ongoing Clinical Trials Overview 21
Table 21: Cellnovo Wireless Insulin Pump System - Product Status 21
Table 22: Cellnovo Wireless Insulin Pump System - Product Description 22
Table 23: Wireless Insulin Pump System Integrated With inControl AP - Product Status 22
Table 24: Wireless Insulin Pump System Integrated With inControl AP - Product Description 22
Table 25: Debiotech SA Pipeline Products & Ongoing Clinical Trials Overview 23
Table 26: Jewel Pump - Product Status 23
Table 27: Jewel Pump - Product Description 23
Table 28: JewelPUMP2 - Product Status 24
Table 29: JewelPUMP2 - Product Description 24
Table 30: Hospira Inc Pipeline Products & Ongoing Clinical Trials Overview 25
Table 31: Integrated Symbiq/EndoTool System - Product Status 25
Table 32: Integrated Symbiq/EndoTool System - Product Description 25
Table 33: Insulet Corp Pipeline Products & Ongoing Clinical Trials Overview 26
Table 34: OmniPod - Humalog U200 - Product Status 26
Table 35: OmniPod - Humalog U200 - Product Description 26
Table 36: OmniPod - New Version - Product Status 27
Table 37: OmniPod - New Version - Product Description 27
Table 38: LifeScan Inc Pipeline Products & Ongoing Clinical Trials Overview 28
Table 39: ONETOUCH Ping Verio Insulin Pump With Meter Remote - Product Status 28
Table 40: ONETOUCH Ping Verio Insulin Pump With Meter Remote - Product Description 28
Table 41: MedSolve Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 29
Table 42: Freehand Patch Pump - Product Status 29
Table 43: Freehand Patch Pump - Product Description 29
Table 44: MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 30
Table 45: Angel Touch - Product Status 30
Table 46: Angel Touch - Product Description 30
Table 47: La Fenice V - Product Status 31
Table 48: La Fenice V - Product Description 31
Table 49: Phluid Corporation Pipeline Products & Ongoing Clinical Trials Overview 32
Table 50: Ambulatory Diabetes Pump - Product Status 32
Table 51: Ambulatory Diabetes Pump - Product Description 32
Table 52: Roche Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview 33
Table 53: Solo MicroPump Insulin Delivery System - Product Status 33
Table 54: Solo MicroPump Insulin Delivery System - Product Description 33
Table 55: Roche Diabetes Care Inc - Ongoing Clinical Trials Overview 34
Table 56: Solo MicroPump Insulin Delivery System - Patient-reported Outcomes with the Accu-Chek Solo Micropump System vs. Multiple Daily Injection Therapy Versus Mylife OmniPod in People with Type I Diabetes 35
Table 57: Sensile Medical AG Pipeline Products & Ongoing Clinical Trials Overview 36
Table 58: Bolus Patch - Product Status 36
Table 59: Bolus Patch - Product Description 36
Table 60: SFC Fluidics LLC Pipeline Products & Ongoing Clinical Trials Overview 37
Table 61: Disposable Insulin Patch Pump - Product Status 37
Table 62: Disposable Insulin Patch Pump - Product Description 37
Table 63: Pod Automated Insulin Delivery Device - Product Status 37
Table 64: Pod Automated Insulin Delivery Device - Product Description 38
Table 65: Spring Health Solutions Ltd. Pipeline Products & Ongoing Clinical Trials Overview 39
Table 66: Spring Zone Hybrid Patch Pump - Product Status 39
Table 67: Spring Zone Hybrid Patch Pump - Product Description 39
Table 68: Tandem Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview 40
Table 69: Next-Generation t:slim X2 Insulin Pump - Pediatric - Product Status 40
Table 70: Next-Generation t:slim X2 Insulin Pump - Pediatric - Product Description 41
Table 71: t:slim X2 Pump With Predictive Low Glucose Suspend Algorithm - Product Status 41
Table 72: t:slim X2 Pump With Predictive Low Glucose Suspend Algorithm - Product Description 41
Table 73: t:sport - Product Status 42
Table 74: t:sport - Product Description 42
Table 75: Univlabs Technologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 43
Table 76: Insulin Patch Pump - Product Status 43
Table 77: Insulin Patch Pump - Product Description 43
Table 78: ViCentra BV Pipeline Products & Ongoing Clinical Trials Overview 44
Table 79: Kaleido Insulin Pump - Product Status 44
Table 80: Kaleido Insulin Pump - Product Description 44
Table 81: Ypsomed Holding AG Pipeline Products & Ongoing Clinical Trials Overview 45
Table 82: Lanzi - Product Status 45
Table 83: Lanzi - Product Description 45
Table 84: mylife YpsoPod Insulin Pump - Tubeless - Product Status 46
Table 85: mylife YpsoPod Insulin Pump - Tubeless - Product Description 46
Table 86: mylife YpsoPump - Product Status 46
Table 87: mylife YpsoPump - Product Description 46
Table 88: Glossary 176

List Of Figures

1.2 List of Figures
Figure 1: Insulin Pumps - Pipeline Products by Stage of Development 9
Figure 2: Insulin Pumps - Pipeline Products by Segment 10
Figure 3: Insulin Pumps - Pipeline Products by Territory 11
Figure 4: Insulin Pumps - Pipeline Products by Regulatory Path 12
Figure 5: Insulin Pumps - Pipeline Products by Estimated Approval Date 13
Figure 6: Insulin Pumps - Ongoing Clinical Trials 14

Global Tubeless Insulin Pump Market Research Report 2019-2023

In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Tubeless Insulin Pump Report by Material, Application, and

USD 2850 View Report

Insulin Pumps - Medical Devices Pipeline Assessment, 2019

Insulin Pumps - Medical Devices Pipeline Assessment, 2019Medical Devices sector report, Insulin Pumps - Medical Devices Pipeline Assessment, 2019 provides an overview of Insulin Pumps currently in pipeline stage.The report

USD 4000 View Report

Asia Pacific Patch Insulin Pumps Market Report (2014-2024) - Market Size, Share, Price, Trend and Forecast

Abstract:The Asia Pacific Patch Insulin Pumps market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD

USD 3000 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available